Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF, a phase II randomised, double-blind, placebo-controlled, dose-finding study.
- DOI
- 10.1183/13993003.01551-2024
- Published
- 2025 Jan
- Container
- The European respiratory journal
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1183/13993003.01551-2024,
title = {Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF, a phase II randomised, double-blind, placebo-controlled, dose-finding study.},
author = {Chalmers JD and Shteinberg M and Mall MA and O'Donnell AE and Watz H and Gupta A and Frahm E and Eleftheraki A and Rauch J and Chotirmall SH and Armstrong AW and Eickholz P and Hasegawa N and Sauter W and McShane PJ},
year = {2025},
journal = {The European respiratory journal},
doi = {10.1183/13993003.01551-2024},
url = {https://doi.org/10.1183/13993003.01551-2024}
}RIS
TY - JOUR TI - Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF, a phase II randomised, double-blind, placebo-controlled, dose-finding study. AU - Chalmers JD AU - Shteinberg M AU - Mall MA AU - O'Donnell AE AU - Watz H AU - Gupta A AU - Frahm E AU - Eleftheraki A AU - Rauch J AU - Chotirmall SH AU - Armstrong AW AU - Eickholz P AU - Hasegawa N AU - Sauter W AU - McShane PJ PY - 2025 JO - The European respiratory journal DO - 10.1183/13993003.01551-2024 UR - https://doi.org/10.1183/13993003.01551-2024 ER -
APA
JD, C., M, S., MA, M., AE, O., H, W., A, G., E, F., A, E., J, R., SH, C., AW, A., P, E., N, H., W, S., & PJ, M. (2025). Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF, a phase II randomised, double-blind, placebo-controlled, dose-finding study.. The European respiratory journal. https://doi.org/10.1183/13993003.01551-2024
Source records
- pubmed · retrieved 2026-09-25T08:10:04.448Z